New study to track Real-World results of ultrasound therapy for prostate cancer
NCT ID NCT07203482
First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 29 times
Summary
This study will follow 300 men with early-stage prostate cancer who choose to be treated with high-intensity focused ultrasound (HIFU). Researchers will collect data on cancer control, side effects, and urinary and sexual function for years after treatment. The goal is to better understand the benefits and risks of HIFU and improve patient care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NYU Langone Health - Cobble Hill
RECRUITINGBrooklyn, New York, 11201, United States
-
NYU Langone Health - Tisch Hospital
RECRUITINGNew York, New York, 10016, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
High-Intensity Focused Ultrasound (HIFU) ablation
What this could lead to
If successful, this study could provide clearer data on how well HIFU controls prostate cancer and its impact on quality of life, helping doctors and patients make better treatment decisions.
What could go wrong
This is an observational study, not a controlled trial, so it cannot prove HIFU is better than other treatments. Results may not apply to all patients, and long-term outcomes are still uncertain.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.